Work

ASO Perspectives: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer: Never Stop Questioning

Year: 2022

Type: editorial

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-021-11276-4

Authors: Bryan J. Schneider, Andrew C. Chang

Institutions: University of Michigan, Michigan Medicine

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4213093891

Cites: 14

Cited by: 2

Related to: 10